Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1974 2
1977 1
1978 2
1983 1
1984 1
1985 7
1986 1
1987 1
1988 1
1989 1
1990 2
1991 2
1992 2
1995 1
1997 1
2000 2
2006 1
2008 1
2009 1
2010 2
2011 3
2012 1
2013 6
2014 1
2015 6
2016 6
2017 4
2018 9
2019 5
2020 8
2021 12
2022 15
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
Butler CC, Hobbs FDR, Gbinigie OA, Rahman NM, Hayward G, Richards DB, Dorward J, Lowe DM, Standing JF, Breuer J, Khoo S, Petrou S, Hood K, Nguyen-Van-Tam JS, Patel MG, Saville BR, Marion J, Ogburn E, Allen J, Rutter H, Francis N, Thomas NPB, Evans P, Dobson M, Madden TA, Holmes J, Harris V, Png ME, Lown M, van Hecke O, Detry MA, Saunders CT, Fitzgerald M, Berry NS, Mwandigha L, Galal U, Mort S, Jani BD, Hart ND, Ahmed H, Butler D, McKenna M, Chalk J, Lavallee L, Hadley E, Cureton L, Benysek M, Andersson M, Coates M, Barrett S, Bateman C, Davies JC, Raymundo-Wood I, Ustianowski A, Carson-Stevens A, Yu LM, Little P; PANORAMIC Trial Collaborative Group. Butler CC, et al. Among authors: lowe dm. Lancet. 2023 Jan 28;401(10373):281-293. doi: 10.1016/S0140-6736(22)02597-1. Epub 2022 Dec 22. Lancet. 2023. PMID: 36566761 Free PMC article. Clinical Trial.
Norovirus infection in primary immune deficiency.
Brown LK, Clark I, Brown JR, Breuer J, Lowe DM. Brown LK, et al. Among authors: lowe dm. Rev Med Virol. 2017 May;27(3):e1926. doi: 10.1002/rmv.1926. Epub 2017 Mar 8. Rev Med Virol. 2017. PMID: 28271593 Review.
Viral infection in primary antibody deficiency syndromes.
Jones TPW, Buckland M, Breuer J, Lowe DM. Jones TPW, et al. Among authors: lowe dm. Rev Med Virol. 2019 Jul;29(4):e2049. doi: 10.1002/rmv.2049. Epub 2019 Apr 24. Rev Med Virol. 2019. PMID: 31016825 Review.
Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease.
Gbinigie O, Ogburn E, Allen J, Dorward J, Dobson M, Madden TA, Yu LM, Lowe DM, Rahman N, Petrou S, Richards D, Hood K, Patel M, Saville BR, Marion J, Holmes J, Png ME, Hayward G, Lown M, Harris V, Jani B, Hart N, Khoo S, Rutter H, Chalk J, Standing JF, Breuer J, Lavallee L, Hadley E, Cureton L, Benysek M, Andersson MI, Francis N, Thomas NPB, Evans P, van Hecke O, Koshkouei M, Coates M, Barrett S, Bateman C, Davies J, Raymundo-Wood I, Ustianowski A, Nguyen-Van-Tam J, Carson-Stevens A, Hobbs R, Little P, Butler CC. Gbinigie O, et al. Among authors: lowe dm. BMJ Open. 2023 Aug 7;13(8):e069176. doi: 10.1136/bmjopen-2022-069176. BMJ Open. 2023. PMID: 37550022 Free PMC article.
Neutrophils in tuberculosis: friend or foe?
Lowe DM, Redford PS, Wilkinson RJ, O'Garra A, Martineau AR. Lowe DM, et al. Trends Immunol. 2012 Jan;33(1):14-25. doi: 10.1016/j.it.2011.10.003. Epub 2011 Nov 15. Trends Immunol. 2012. PMID: 22094048 Review.
Early phase dose-finding trials in virology.
Dehbi HM, Lowe DM, O'Quigley J. Dehbi HM, et al. Among authors: lowe dm. Stat Med. 2021 Jan 30;40(2):240-253. doi: 10.1002/sim.8771. Epub 2020 Oct 14. Stat Med. 2021. PMID: 33053601
Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein.
Upasani V, Townsend K, Wu MY, Carr EJ, Hobbs A, Dowgier G, Ragno M, Herman LS, Sharma S, Shah D, Lee SFK, Chauhan N, Glanville JM, Neave L, Hanson S, Ravichandran S, Tynan A, O'Sullivan M, Moreira F, Workman S, Symes A, Burns SO, Tadros S, Hart JCL, Beale RCL, Gandhi S, Wall EC, McCoy L, Lowe DM. Upasani V, et al. Among authors: lowe dm. Clin Infect Dis. 2023 Oct 5;77(7):950-960. doi: 10.1093/cid/ciad368. Clin Infect Dis. 2023. PMID: 37338118 Free PMC article.
Recurrent Campylobacter jejuni Infections with In Vivo Selection of Resistance to Macrolides and Carbapenems: Molecular Characterization of Resistance Determinants.
Nunes A, Oleastro M, Alves F, Liassine N, Lowe DM, Benejat L, Ducounau A, Jehanne Q, Borges V, Gomes JP, Godbole G, Philippe L. Nunes A, et al. Among authors: lowe dm. Microbiol Spectr. 2023 Aug 17;11(4):e0107023. doi: 10.1128/spectrum.01070-23. Epub 2023 Jun 26. Microbiol Spectr. 2023. PMID: 37358443 Free PMC article.
114 results